Medical Advocates

HCV Infection/Disease

General Measures


HCV Main Page Main New/Newsworthy    Home Page    

Last Update:  January 02, 2018
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Measures

     Journal Papers, Abstracts, and Commentaries      


Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.
Hickman M, De Angelis D, Vickerman P, et al
Curr Opin Infect Dis. 2015 Dec;28(6):576-82.

Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
He T, Li K, Roberts MS, et al
Ann Intern Med
. 2015 Nov 24.


Consensus Document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children
Grupo de expertos de la Secretaría del Plan Nacional sobre el Sida (SPNS); Grupo de Estudio de Sida (GeSIDA); Sociedad Española de Medicina y Seguridad del Trabajo (SEMST); Grupo de Estudio de Sida (GeSIDA); Sociedad Española de Medicina y Seguridad del Trabajo (SEMST); Sociedad Española de Medicina Preventiva;  et al
Enferm Infecc Microbiol Clin
. 2015 Sep 22

An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.
Perlman DC, Jordan AE, Uuskula A,  et al
Int J Drug Policy. 2015 Apr 27.

Hepatitis C Prevention and Needle Exchange Programs in Rhode Island: ENCORE.
Joseph R, Kofman A, Larney S, Fitzgerald P.

R I Med J (2013)
. 2014 Jul 1;96(7):31-4.


Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.
Martin NK, Hickman M, Hutchinson SJ,  et al
Clin Infect Dis. 2013 Aug;57 Suppl 2:S39-45

Healthcare workers and prevention of hepatitis C virus transmission: exploring knowledge, attitudes and evidence-based practices in hemodialysis units in Italy.
Bianco A, Bova F, Nobile CG,  et al
BMC Infect Dis. 2013 Feb 7;13(1):76.

Best strategies for global HCV eradication.
Hagan LM, Schinazi RF
Liver Int. 2013 Feb;33 Suppl 1:68-79.

Treatment as Prevention: Should Hepatitis C Learn the Lessons from HIV?
Fernandez-Montero JV, Aspinall EJ, Burns JE.
. 2017 May 23;19(2).

Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.
Davis SM, Daily S, Kristjansson AL,  et al 
Harm Reduct J. 2017 May 17;14(1):2

Preventive versus "on-demand" nutritional support during antiviral treatment for hepatitis C: a randomized controlled trial.
Huisman EJ, van Hoek B, van Soest H, et al
J Hepatol. 2012 Jun 30


Centers for disease control and prevention initiatives to prevent hepatitis C virus infection: a selective update.
Smith BD, Jorgensen C, Zibbell JE, Beckett GA.
Clin Infect Dis
. 2012 Jul;55 Suppl 1:S49-53.

Methods used to reduce the prevalence of hepatitis C in a dialysis unit.
Hussein MM, Mooij JM
Saudi J Kidney Dis Transpl. 2010 Sep;21(5):909-13

Hepatitis C virus: Prevention, screening, and interpretation of assays.
Albeldawi M, Ruiz-Rodriguez E, Carey WD.
Cleve Clin J Med
. 2010 Sep;77(9):616-26

Epidemiology, Surveillance, and Prevention of Hepatitis C Virus Infections in
Hemodialysis Patients.
Patel PR, Thompson ND, Kallen AJ, Arduino MJ.
Am J Kidney Dis
. 2010 Jun 4


    Conference Reports, Abstracts, and Posters

The effectiveness of needle/syringe structural interventions to reduce HCV and HIV infection
A. Abdul-Quader, J. Feelemyer, D.C. Des Jarlais
(XIX International AIDS Conference


     Journal Papers, Abstracts, and Commentaries
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments.
Scott N, McBryde E, Vickerman P,  et al
. 2015 Aug 20;13:198.

Assessing the feasibility of hepatitis C virus vaccine trials: Results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.
White B, Madden A, Prins M,  et al
Vaccine. 2014 Aug 12.

Why is it so difficult to develop a hepatitis C virus preventive vaccine?
Zingaretti C, De Francesco R, Abrignani S.
Clin Microbiol Infect. 2014 May;20 Suppl 5:103-9.

Hepatitis C virus vaccines among people who inject drugs.
Cox AL, Thomas DL
Clin Infect Dis. 2013 Aug;57 Suppl 2:S46-50.

Ever closer to a prophylactic vaccine for HCV.
Swadling L, Klenerman P, Barnes E
Expert Opin Biol Ther. 2013 May 7

Hepatitis C virus vaccines in the era of new direct-acting antivirals.
Shi C, Ploss A.
Expert Rev Gastroenterol Hepatol. 2013 Feb;7(2):171-85.

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.
Feinstone SM, Hu DJ, Major ME
Clin Infect Dis. 2012 Jul;55 Suppl 1:S25-32.

The More You Look, the More You Find: Effects of Hepatitis C Virus Testing Interval on Reinfection
Incidence and Clearance and Implications for Future Vaccine Study Design.
Vickerman P, Grebely J, Dore GJ,  et al

J Infect Dis
2012 Mar 28.

Progress toward development of a hepatitis C vaccine with broad shoulders.
Ray R
Sci Transl Med. 2011 Aug 3;3(94):94ps33


HCV Main Page Main New/Newsworthy    Home Page    

HCV Prevention